Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ganmao Granules
- Development stage
- Unknown
- Lead developer
- Hebei Wanbang Fu Lin Pharmaceutical
- Administration
- Oral
01
Overview
Ganmao Granules (感冒颗粒) is a traditional Chinese medicine (TCM) formulation produced by Hebei Wanbang Fu Lin Pharmaceutical. It is an over-the-counter (OTC) herbal remedy provided in oral granule form, specifically indicated for the symptomatic relief of the common cold and upper respiratory tract infections. The formulation typically includes a variety of herbs such as *Schizonepeta tenuifolia*, *Mentha haplocalyx*, and *Isatis tinctoria*, which are traditionally used to dispel wind, clear heat, and resolve the exterior. As a standardized TCM product, it is widely used in China to treat symptoms including fever, headache, nasal congestion, and sore throat.
- Other names
- 感冒颗粒Ganmao Keli
Beyond the preview
Go deeper on Ganmao Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ganmao Granules.